Buyse, C.; Joudiou, N.; Warscotte, A.; Richiardone, E.; Mignion, L.; Corbet, C.; Gallez, B.
Evaluation of Syrosingopine, an MCT Inhibitor, as Potential Modulator of Tumor Metabolism and Extracellular Acidification. Metabolites 2022, 12, 557.
https://doi.org/10.3390/metabo12060557
AMA Style
Buyse C, Joudiou N, Warscotte A, Richiardone E, Mignion L, Corbet C, Gallez B.
Evaluation of Syrosingopine, an MCT Inhibitor, as Potential Modulator of Tumor Metabolism and Extracellular Acidification. Metabolites. 2022; 12(6):557.
https://doi.org/10.3390/metabo12060557
Chicago/Turabian Style
Buyse, Chloe, Nicolas Joudiou, Aude Warscotte, Elena Richiardone, Lionel Mignion, Cyril Corbet, and Bernard Gallez.
2022. "Evaluation of Syrosingopine, an MCT Inhibitor, as Potential Modulator of Tumor Metabolism and Extracellular Acidification" Metabolites 12, no. 6: 557.
https://doi.org/10.3390/metabo12060557
APA Style
Buyse, C., Joudiou, N., Warscotte, A., Richiardone, E., Mignion, L., Corbet, C., & Gallez, B.
(2022). Evaluation of Syrosingopine, an MCT Inhibitor, as Potential Modulator of Tumor Metabolism and Extracellular Acidification. Metabolites, 12(6), 557.
https://doi.org/10.3390/metabo12060557